YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Stevens Johnson Syndrome


AddThis Social Bookmark Button

Stevens Johnson Syndrome (SJS)

Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are two forms of the skin disease that can cause rash, skin peeling, and sores on the mucous membranes. Stevens Johnson Syndrome is an immune-complex–mediated hypersensitivity disorder that may be caused by many drugs, viral infections, and malignancies. Often, the drugs causing the onset of Stevens Johnson Syndrome, such as Bextra, did not have warnings placed on their labels until recently. Patients unknowingly took these drugs and many developed the potentially fatal Stevens Johnson Syndrome.

In Stevens Johnson Syndrome, a person has blistering of mucous membranes, typically in the mouth, eyes, and vagina, and patchy areas of rash. In toxic epidermal necrolysis, there is a similar blistering of mucous membranes. However, in addition to blistering, the entire epidermis peels off in sheets from large areas of the body. Both disorders can be life threatening.

Causes of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis are certain drugs in the following classes: non-steroidal anti-inflammatory drugs (both prescription and over the counter), sulfa antibiotics, antibiotics, barbiturates, anticonvulsants, anti-tuberculosis drugs, and the drug allopurinol. In rare cases SJS is caused by a bacterial infection.

If you or a loved one has taken either prescription or over the counter drugs and has been diagnosed with Stevens Johnson Syndrome (SJS), please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.

Stevens Johnson SyndromeRSS Feed

Intelence Linked to Stevens-Johnson Syndrome, Other Serious Skin Reactions

Aug 27, 2009 | Parker Waichman Alonso LLP
Intelence (etravirine), an HIV medication made by Johnson & Johnson's Tibotec division, has been associated with serious skin reactions, including Stevens-Johnson syndrome and   toxic epidermal necrolysis. The company recently sent a  letter to health care providers informing them that the prescribing information for Intelence would be updated  to include information about systemic hypersensitivity reactions, sometimes accompanied by liver failure, that have occurred in...

Revlimid Linked to Steven-Johnson Syndrome, Toxic Epidermal Necrolysis

Sep 19, 2008 | Parker Waichman Alonso LLP
Revlimid, a blood cancer drug made by Celgene Corp., has been associated with Stevens-Johnson Syndrome and toxic epidermal necrolysis, serious and potentially fatal skin disorders. A spokesperson for Celgene told The Wall Street Journal that it  is likely the label for Revlimid would be updated in the future to include reports of the skin reactions.Revlimid was the first of Celgene's new class of oral cancer drugs called IMiDs (immunomodulatory drug). IMiDs modify or regulate the...

Family of Girl Blinded by Stevens-Johnson Syndrome Sues Maker of Children's Motrin

Jun 16, 2008 | Parker Waichman Alonso LLP
The family of a young girl blinded as a result of Stevens-Johnson Syndrome blames Children's Motrin for her injuries, and has taken the maker of the over-the-counter pain reliever to court.  The family's lawsuit is seeking better labeling for the pain reliever, as well as compensatory and punitive damages from McNeil PPC, and its parent, Johnson &  Johnson.  Stevens-Johnson Syndrome is a sometimes life-threatening hypersensitivity complex affecting the skin and the mucous...

Carbamazepine Gets Warning on Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis

Dec 12, 2007 | Parker Waichman Alonso LLP
Carbamazepine, a drug used to treat epilepsy and bipolar disorder, will now come with new warnings that Asian patients should undergo genetic testing before using the drug.  According to the Food & Drug Administration (FDA), a human leukocyte antigen called HLA-B*1502 that is exclusive to people with Asian ancestry makes it more likely that carbamazepine will cause the serious skin disorders Stevens-Johnson Syndrome  and toxic epidermal necrolysis.  Carbamazepine is an...

Stevens-Johnson Syndrome Affects Mother and Son Taking Nevirapine

Jun 3, 2005 | www.aidsmap.com
Two cases of the rare side-effect of nevirapine, Stevens-Johnson syndrome, involving a mother and her son, are reported in the June 10th edition of AIDS. The investigators "are unaware of any previous familial clustering" of Stevens-Johnson syndrome associated with nevirapine treatment.The non-nucleoside reverse transcriptase inhibitor (NNRTI) nevirapine is a standard component in first-line HAART regimens used in resource-limited settings. It is likely to remain widely used once...

More Stevens Johnson Syndrome News

Stevens Johnson Syndrome
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

If you believe SJS or TEN are due to a drug you took, please list drug:

Please describe your case:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News